http://www.unboundmedicine.com/medline/ebm/research/eptifibatideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19888429/full_citation/The_Roles_of_Platelet_GPIIb/IIIa_and_alphavbeta3_Integrins_during_HeLa_Cells_Adhesion_Migration_and_Invasion_to_Monolayer_Endothelium_under_Static_and_Dynamic_Shear_Flow_Liu Y, Zhao F, Gu W, et al. 
The Roles of Platelet GPIIb/IIIa and alphavbeta3 Integrins during HeLa Cells Adhesion, Migration, and Invasion to Monolayer Endothelium under Static and Dynamic Shear Flow. [Journal Article]
J Biomed Biotechnol 2009.:829243.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19882074/full_citation/Glycoprotein_IIb/IIIa_antagonists_Zeymer U, Zahn R 
Glycoprotein IIb/IIIa antagonists. [Journal Article]
Hamostaseologie 2009 Sep; 29(4):334-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19875386/full_citation/Risk_profile_and_benefits_from_Gp_IIb_IIIa_inhibitors_among_patients_with_ST_segment_elevation_myocardial_infarction_treated_with_primary_angioplasty:_a_meta_regression_analysis_of_randomized_trials_De Luca G, Navarese E, Marino P 
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. [JOURNAL ARTICLE]
Eur Heart J 2009 Oct 28.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19844100/full_citation/Safety_of_Eptifibatide_for_Subcortical_Stroke_Progression_Martin-Schild S, Shaltoni H, Abraham AT, et al. 
Safety of Eptifibatide for Subcortical Stroke Progression. [JOURNAL ARTICLE]
Cerebrovasc Dis 2009 Oct 16; 28(6):595-600.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19834397/full_citation/Safety_effectiveness_and_practicality_of_endovascular_therapy_within_the_first_3_hours_of_acute_ischemic_stroke_onset_Mathews MS, Sharma J, Snyder KV, et al. 
Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. [Journal Article]
Neurosurgery 2009 Nov; 65(5):860-5; discussion 865.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19830082/full_citation/A_retrospective_analysis_and_case_series_of_glycoprotein_IIb/IIIa_inhibitor_associated_diffuse_alveolar_hemorrhage:_two_case_reports_Mikkilineni H, Bruhl SR, Colyer WR, et al. 
A retrospective analysis and case series of glycoprotein IIb/IIIa inhibitor associated diffuse alveolar hemorrhage: two case reports. [Journal Article]
Cases J 2009.:8553.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19751625/full_citation/Facilitated_angioplasty_with_combo_therapy_among_patients_with_ST_segment_elevation_myocardial_infarction:_a_meta_analysis_of_randomized_trials_De Luca G, Marino P 
Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. [Journal Article, Meta-Analysis]
Am J Emerg Med 2009 Jul; 27(6):683-90.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19717184/full_citation/Otamixaban_for_the_treatment_of_patients_with_non_ST_elevation_acute_coronary_syndromes__SEPIA_ACS1_TIMI_42_:_a_randomised_double_blind_active_controlled_phase_2_trial_Sabatine MS, Antman EM, Widimsky P, et al. 
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial. [Clinical Trial, Phase II, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Lancet 2009 Sep 5; 374(9692):787-95.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19668787/full_citation/Effect_of_operator_and_institutional_volume_on_clinical_outcomes_after_percutaneous_coronary_interventions_performed_in_Canada_and_the_United_States:_A_brief_report_from_the_Enhanced_Suppression_of_the_Platelet_glycoprotein_IIb/IIIa_Receptor_with_Integrilin_Therapy__ESPRIT__study_Madan M, Nikhil J, Hellkamp AS, et al. 
Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: A brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study. [JOURNAL ARTICLE]
Can J Cardiol 2009 Aug; 25(8):e269-e272.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19657317/full_citation/Characterization_of_static_adhesion_of_human_platelets_in_plasma_to_protein_surfaces_in_microplates_Eriksson AC, Whiss PA 
Characterization of static adhesion of human platelets in plasma to protein surfaces in microplates. [Journal Article]
Blood Coagul Fibrinolysis 2009 Apr; 20(3):197-206.
Abstract | Full Citation